Synthesis and pharmacological evaluation of piperidine (piperazine)-substituted benzoxazole derivatives as multi-target antipsychotics
摘要:
The present study describes the optimization of a series of novel benzoxazole-piperidine (piperazine) derivatives combining high dopamine D-2 and serotonin 5-HT1A, 5-HT2A receptor affinities. Of these derivatives, the pharmacological features of compound 29 exhibited high affinities for the DA D-2, 5-HT1A and 5-HT2A receptors, but low affinities for the 5-HT2C and histamine H-1 receptors and human ether-a-go-go-related gene (hERG) channels. Furthermore, compound 29 reduced apomorphine-induced climbing and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head twitching without observable catalepsy, even at the highest dose tested. Thus, compound 29 is a promising candidate as a multi-target antipsychotic treatment. (C) 2015 Elsevier Ltd. All rights reserved.
Phosphonium acidic ionic liquid: an efficient and recyclable homogeneous catalyst for the synthesis of 2-arylbenzoxazoles, 2-arylbenzimidazoles, and 2-arylbenzothiazoles
作者:Quang The Nguyen、Anh-Hung Thi Hang、Thuy-Linh Ho Nguyen、Duy-Khiem Nguyen Chau、Phuong Hoang Tran
DOI:10.1039/c8ra01709c
日期:——
A highly efficient and green strategy for the synthesis of 2-arylbenzoxazoles, 2-arylbenzimidazoles, and 2-arylbenzothiazoles catalyzed by phosphonium acidic ionic liquid has been developed via the condensation of o-aminophenol, o-phenylenediamines, and o-aminothiophenol, respectively, with aldehydes. The reaction has a good yield, the broad substrate scope, and mild condition. Triphenyl(butyl-3-s
分别通过邻氨基苯酚、邻苯二胺和邻氨基苯硫酚的缩合,开发了一种由鏻酸性离子液体催化合成 2-芳基苯并恶唑、2-芳基苯并咪唑和 2-芳基苯并噻唑的高效绿色策略,与醛。该反应收率好,底物范围广,条件温和。三苯基(丁基-3-磺酰基)鏻甲苯磺酸盐催化剂通过一锅法合成很容易从廉价且可用的起始材料中获得。其结构经1 H NMR、13 C NMR、31P NMR和FT-IR技术。热稳定性和酸度等其他性质采用TGA和Hammett酸度函数法测定。有趣的是,催化剂在第四次复苏之前仍能保持其持续的出色表现。
Chromophore Coated Metal Oxide Particles
申请人:Schehlmann Volker
公开号:US20090291107A1
公开(公告)日:2009-11-26
The invention provides coated metal oxide particles, wherein metal oxide particles are coated with at least one type of crosslinkable chromophore with UV-A and/or UV-B and/or UV-C filter and/or broadband activity and optionally at least one type of crosslinkable monomer which does not have UV-A and/or UV-B and/or UV-C and/or broadband filter activity and process to obtain coated metal oxide particles and their use especially in cosmetic or dermatological formulations for the protection against harmful effects of sunlight.
Microcapsules with uv filter activity and process for producing them
申请人:Berg-Schultz Katja
公开号:US20070190325A1
公开(公告)日:2007-08-16
The invention provides a process for producing microcapsules with UV filter activity, wherein at least one type of crosslinkable chromophore with UV-A and/or UV-B and/or UV-C filter activity and optionally at least one type of crosslinkable monomer which does not have UV-A and/or UV-B and/or UV-C filter activity are subjected to a crosslinking reaction in the absence of non-crosslinkable chromophores with UV-A and/or UV-B and/or UV-C filter activity and microcapsules obtainable by this process.
MICROCAPSULES WITH UV FILTER ACTIVITY AND PROCESS FOR PRODUCING THEM
申请人:BERG-SCHULTZ Katja
公开号:US20120022265A1
公开(公告)日:2012-01-26
The invention provides a process for producing microcapsules with UV filter activity, wherein at least one type of crosslinkable chromophore with UV-A and/or UV-B and/or UV-C filter activity and optionally at least one type of crosslinkable monomer which does not have UV-A and/or UV-B and/or UV-C filter activity are subjected to a crosslinking reaction in the absence of non-crosslinkable chromophores with UV-A and/or UV-B and/or UV-C filter activity and microcapsules obtainable by this process.